The most effective intervention that nobody recommends

By Nicolas Marty and Kevin Vezirian In 2023, Science reported that as many as nine in ten laboratory animal personnel will experience compassion fatigue at some point in their careers. For a workplace problem of that magnitude, occupational health offers a standard instrument: the hierarchy of controls, which ranks responses to a hazard from most […]

Read More…

Will history repeat itself? The Stanford Prison Experiment

By Brianne Helfrich and Mariah Chobany Netflix just announced that they will be re-creating the Stanford Prison Experiment as a reality tv show (titled The New Stanford Prison Experiment) airing this October. The six 45-minute episode series involve 30 participants, and this news has sparked online viral debate and disbelief with many expressing strong concerns […]

Read More…

Placebos and ethics in digital therapeutics

By Jacqueline Lutz & Lindsay Ayearst In applied digital health, questions about evidence generation are inseparable from how products are built and whether they ever reach patients. Many scientists working on digital therapeutics are academically trained to run controlled clinical studies, behavioral experiments, or to study specific behavioral intervention mechanisms. That rigor does not disappear […]

Read More…

When evidence has only one arm: The ethical challenges of single arm trials

By Chiara Mannelli and Giuseppe Traversa Randomized controlled trials (RCTs) have long been regarded as the “gold standard” for testing new treatments. Yet in recent years, an increasing number of marketing authorizations – especially for cancer drugs – have been based on single arm trials (SATs). In these studies, all patients receive the experimental treatment, […]

Read More…

Teens on the ethics panel: Why IRBs should hear from young people

By Samuel Asiedu Owusu and Claudia Passos-Ferreira Pediatric research is often designed for children but reviewed without them. When research involves children, adults make the ethical calls. They design the studies, write the consent forms, and sit on the ethics committees that approve them. They don’t always get it right. Listening to children can make […]

Read More…

The USA’s Food and Drug Administration and informed consent

By Hugh Davies The Food and Drug Administration’s (FDA) initiative Over the last three decades seeking consent of patients or volunteers to join a medical research study has become dominated by an increasingly lengthy, opaque and Participant Information Sheet (PIS), shielding the researcher from liability. The FDA argues that Informed consent documents are often long, […]

Read More…